Tobira Therapeutics
Manalapan
About Tobira Therapeutics
Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $99.0M
- Funding stage: M&A
- Last round: Convertible Note (Mar 2015)
- Ticker: nasdaq:TBRA
- Website: tobiratherapeutics.com
- Phone: 16507453883
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tobira-therapeutics-1615502 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.